BST
NVO

Bath Savings Trust’s Novo Nordisk NVO Stock Holding History

Bath Savings Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Sell
8,257
-993
-11% -$42.7K 0.04% 139
2026
Q1 		$340K Sell
9,250
-8,766
-49% -$415K 0.04% 142
2025
Q4 		$917K Sell
18,016
-7,988
-31% -$408K 0.09% 95
2025
Q3 		$1.44M Buy
26,004
+3,521
+16% +$206K 0.14% 83
2025
Q2 		$1.55M Buy
22,483
+14,692
+189% +$999K 0.16% 79
2025
Q1 		$541K Sell
7,791
-193
-2% -$15.9K 0.06% 116
2024
Q4 		$687K Sell
7,984
-915
-10% -$98.9K 0.07% 113
2024
Q3 		$1.06M Sell
8,899
-420
-5% -$56K 0.11% 96
2024
Q2 		$1.33M Sell
9,319
-145
-2% -$19.2K 0.14% 86
2024
Q1 		$1.22M Sell
9,464
-1,500
-14% -$179K 0.13% 91
2023
Q4 		$1.13M Sell
10,964
-163
-1% -$16.1K 0.13% 93
2023
Q3 		$1.01M Sell
11,127
-71
-0.6% -$6.25K 0.12% 91
2023
Q2 		$906K Sell
11,198
-120
-1% -$9.8K 0.11% 96
2023
Q1 		$901K Sell
11,318
-1,000
-8% -$70.9K 0.11% 99
2022
Q4 		$834K Sell
12,318
-150
-1% -$8.79K 0.11% 98
2022
Q3 		$621K Sell
12,468
-200
-2% -$10.7K 0.09% 103
2022
Q2 		$706K Sell
12,668
-100
-0.8% -$5.55K 0.09% 101
2022
Q1 		$709K Sell
12,768
-200
-2% -$10.3K 0.08% 103
2021
Q4 		$726K Sell
12,968
-40
-0.3% -$2.17K 0.08% 106
2021
Q3 		$624K Sell
13,008
-400
-3% -$19.3K 0.07% 110
2021
Q2 		$562K Sell
13,408
-300
-2% -$11.6K 0.07% 115
2021
Q1 		$462K Sell
13,708
-400
-3% -$14.2K 0.06% 120
2020
Q4 		$493K Sell
14,108
-50
-0.4% -$1.73K 0.07% 108
2020
Q3 		$492K Sell
14,158
-1,442
-9% -$48.1K 0.08% 92
2020
Q2 		$511K Sell
15,600
-58
-0.4% -$1.85K 0.09% 88
2020
Q1 		$471K Sell
15,658
-492
-3% -$14.6K 0.1% 84
2019
Q4 		$468K Sell
16,150
-150
-0.9% -$4.15K 0.08% 92
2019
Q3 		$421K Sell
16,300
-300
-2% -$7.59K 0.08% 96
2019
Q2 		$423K Hold
16,600
– – 0.08% 92
2019
Q1 		$435K Sell
16,600
-1,350
-8% -$33.2K 0.09% 92
2018
Q4 		$414K Sell
17,950
-4,750
-21% -$106K 0.1% 85
2018
Q3 		$535K Sell
22,700
-6,100
-21% -$149K 0.12% 87
2018
Q2 		$664K Sell
28,800
-1,850
-6% -$44K 0.16% 84
2018
Q1 		$755K Sell
30,650
-2,150
-7% -$56.4K 0.19% 78
2017
Q4 		$880K Hold
32,800
– – 0.22% 74
2017
Q3 		$790K Sell
32,800
-950
-3% -$21.5K 0.21% 74
2017
Q2 		$724K Sell
33,750
-19,900
-37% -$402K 0.2% 77
2017
Q1 		$919K Sell
53,650
-26,600
-33% -$463K 0.27% 65
2016
Q4 		$1.44M Sell
80,250
-33,860
-30% -$614K 0.44% 55
2016
Q3 		$2.37M Sell
114,110
-7,500
-6% -$186K 0.74% 40
2016
Q2 		$3.27M Sell
121,610
-3,730
-3% -$102K 1.02% 33
2016
Q1 		$3.4M Sell
125,340
-2,890
-2% -$77.4K 1.09% 32
2015
Q4 		$3.72M Sell
128,230
-350
-0.3% -$9.69K 1.25% 26
2015
Q3 		$3.49M Sell
128,580
-830
-0.6% -$23.5K 1.23% 27
2015
Q2 		$3.54M Sell
129,410
-1,790
-1% -$50.3K 1.21% 29
2015
Q1 		$3.5M Sell
131,200
-9,630
-7% -$222K 1.18% 29
2014
Q4 		$2.98M Buy
140,830
+2,700
+2% +$60.3K 1.03% 35
2014
Q3 		$3.29M Buy
138,130
+2,040
+1% +$46.9K 1.24% 28
2014
Q2 		$3.14M Buy
136,090
+20
+0% +$442 1.2% 30
2014
Q1 		$3.1M Buy
136,070
+10,070
+8% +$215K 1.23% 29
2013
Q4 		$2.33M Buy
126,000
+21,600
+21% +$376K 0.93% 38
2013
Q3 		$1.77M Buy
104,400
+8,200
+9% +$138K 0.77% 41
2013
Q2 		$1.49M Buy
+96,200
New +$1.6M 0.7% 45

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Bath Savings Trust's NVO Position: Q2 2026 in Review

Bath Savings Trust reduced its Novo Nordisk (NVO) stake by 11% in Q2 2026, selling an estimated $42.7K and leaving 8,257 shares worth $396K. The position accounts for 0.04% of the portfolio, ranked #139.

Bath Savings Trust first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.72M in Q4 2015. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bath Savings Trust held 8,257 shares of Novo Nordisk worth $396K as of Q2 2026.
  • Bath Savings Trust sold 993 Novo Nordisk shares in Q2 2026, an estimated $42.7K.
  • Novo Nordisk made up 0.04% of Bath Savings Trust's portfolio in Q2 2026, its #139 holding.
  • Bath Savings Trust first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Bath Savings Trust's Novo Nordisk position peaked at $3.72M in Q4 2015.
  • 516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bath Savings Trust's 13F filing for Q2 2026, filed 9 Jul 2026.